Guardant Health (GH) Short Interest Ratio & Short Volume → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Free GH Stock Alerts $19.44 +0.80 (+4.29%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Guardant Health Short Interest DataCurrent Short Volume9,560,000 sharesPrevious Short Volume7,640,000 sharesChange Vs. Previous Month+25.13%Dollar Volume Sold Short$163.09 millionShort Interest Ratio / Days to Cover4.8Last Record DateApril 15, 2024Outstanding Shares121,713,000 sharesPercentage of Shares Shorted7.85%Today's Trading Volume2,808,358 sharesAverage Trading Volume1,835,061 sharesToday's Volume Vs. Average153% Short Selling Guardant Health ? Sign up to receive the latest short interest report for Guardant Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGH Short Interest Over TimeGH Days to Cover Over TimeGH Percentage of Float Shorted Over Time Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Guardant Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20249,560,000 shares $163.09 million +25.1%N/A4.8 $17.06 3/31/20247,640,000 shares $157.61 million -1.6%N/A4 $20.63 3/15/20247,760,000 shares $137.66 million +10.1%N/A4.8 $17.74 2/29/20247,050,000 shares $133.95 million +24.1%N/A4.3 $19.00 2/15/20245,680,000 shares $125.70 million +2.5%N/A3.6 $22.13 1/31/20245,540,000 shares $121.49 million +4.1%N/A3.5 $21.93 Get the Latest News and Ratings for GH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guardant Health and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,320,000 shares $128.74 million +1.7%N/A3.2 $24.20 12/31/20235,230,000 shares $141.47 million -4.7%N/A3.3 $27.05 12/15/20235,490,000 shares $154.76 million -4.4%N/A3.3 $28.19 11/30/20235,740,000 shares $144.48 million -9.5%N/A3.4 $25.17 11/15/20236,340,000 shares $144.68 million -9.4%N/A3.5 $22.82 10/31/20237,000,000 shares $181.16 million -5.0%N/A4.2 $25.88 10/15/20237,370,000 shares $199.21 million +5.1%N/A4.6 $27.03 9/30/20237,010,000 shares $207.78 million +1.5%N/A4.5 $29.64 9/15/20236,910,000 shares $204.05 million -1.4%N/A4.5 $29.53 8/31/20237,010,000 shares $273.95 million +2.5%N/A4 $39.08 8/15/20236,840,000 shares $242.07 million -8.2%N/A3.4 $35.39 7/31/20237,450,000 shares $290.70 million -9.3%N/A3.4 $39.02 7/15/20238,210,000 shares $314.61 million -4.8%N/A3.8 $38.32 6/30/20238,620,000 shares $308.60 million +13.1%N/A4 $35.80 6/15/20237,620,000 shares $288.49 million +10.0%N/A3.5 $37.86 5/31/20236,930,000 shares $203.19 million -2.4%N/A3.4 $29.32 5/15/20237,100,000 shares $198.02 million +11.1%7.3%3.5 $27.89 4/30/20236,390,000 shares $144.16 million -8.6%6.5%3.3 $22.56 4/15/20236,990,000 shares $171.26 million +3.4%7.2%3.7 $24.50 3/31/20236,760,000 shares $158.45 million +7.1%6.9%3.4 $23.44 3/15/20236,310,000 shares $168.98 million -9.9%6.5%3.1 $26.78 2/28/20237,000,000 shares $216.23 million +13.1%7.2%3.4 $30.89 2/15/20236,190,000 shares $179.32 million +11.9%6.3%3.2 $28.97 1/31/20235,530,000 shares $173.81 million -0.4%6.1%3.3 $31.43 1/15/20235,550,000 shares $168.89 million +8.8%5.7%3.5 $30.43 12/30/20225,100,000 shares $138.72 million +18.9%5.3%3.3 $27.20 12/15/20224,290,000 shares $177.01 million +3.9%4.4%3.1 $41.26 11/30/20224,130,000 shares $216.16 million -1.9%4.3%4.1 $52.34 11/15/20224,210,000 shares $215.76 million +5.5%4.4%4.1 $51.25 10/31/20223,990,000 shares $197.51 million +1.8%4.1%4 $49.50 10/15/20223,920,000 shares $191.14 million +4.3%4.1%4 $48.76 9/30/20223,760,000 shares $202.40 million -12.2%3.9%4.1 $53.83 9/15/20224,280,000 shares $252.05 million -7.2%4.5%4.6 $58.89 8/31/20224,610,000 shares $230.78 million +3.1%4.8%4.5 $50.06You need to know these two things about AI stocks ASAP… (Ad)For 40 years, he's been known as one of the world's most bullish investors. Forbes even referred to him a "perma bull"... But he just shocked the world by issuing a massive bear warning about AI stocks.Go here now for this breaking story. GH Short Interest - Frequently Asked Questions What is Guardant Health's current short interest? Short interest is the volume of Guardant Health shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 9,560,000 shares of GH short. Learn More on Guardant Health's current short interest. What is a good short interest ratio for Guardant Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GH shares currently have a short interest ratio of 5.0. Learn More on Guardant Health's short interest ratio. Which institutional investors are shorting Guardant Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Guardant Health: Nomura Holdings Inc., III Capital Management, and Capital Fund Management S.A.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Guardant Health's short interest increasing or decreasing? Guardant Health saw a increase in short interest in April. As of April 15th, there was short interest totaling 9,560,000 shares, an increase of 25.1% from the previous total of 7,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guardant Health's short interest compare to its competitors? Here is how the short interest of companies compare to Guardant Health: Veracyte, Inc. (4.76%), Fortrea Holdings Inc. (5.22%), Viridian Therapeutics, Inc. (15.25%), RadNet, Inc. (4.38%), Castle Biosciences, Inc. (5.29%), Fulgent Genetics, Inc. (3.12%), STAAR Surgical (9.91%), Dyne Therapeutics, Inc. (10.32%), Geron Co. (8.33%), Privia Health Group, Inc. (6.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Guardant Health stock? Short selling GH is an investing strategy that aims to generate trading profit from Guardant Health as its price is falling. GH shares are trading up $0.80 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guardant Health? A short squeeze for Guardant Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GH, which in turn drives the price of the stock up even further. How often is Guardant Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VCYT Short Interest Data FTRE Short Interest Data VRDN Short Interest Data RDNT Short Interest Data CSTL Short Interest Data FLGT Short Interest Data STAA Short Interest Data DYN Short Interest Data GERN Short Interest Data PRVA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GH) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings